M
MDxHealth SA
NASDAQ:MDXH
MDxHealth SA
NASDAQ:MDXH
Price:
3.19
USD
0.95%
Market Closed
Market Cap:
$157.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MDxHealth SA
NASDAQ:MDXH
|
BE |
|
E
|
Evexia Lifecare Ltd
BSE:524444
|
IN |
|
Shenzhen Qingyi Photomask Ltd
SSE:688138
|
CN |
|
Kitazawa Sangyo Co Ltd
TSE:9930
|
JP |
|
Jiangsu Yunyong Electronics and Technology Co Ltd
SSE:688060
|
CN |
|
S
|
SeQuent Scientific Ltd
BSE:512529
|
IN |
|
Everplay Group PLC
LSE:EVPL
|
UK |
|
C
|
CosNine Co Ltd
KOSDAQ:082660
|
KR |
Relative Value
The Relative Value of one MDXH stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.19 USD, MDxHealth SA is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MDXH Relative Value
HIDDEN
Multiples Across Competitors
MDXH Competitors Multiples
MDxHealth SA Competitors
MDxHealth SA Competitors
All Countries
| Market Cap | P/S | P/E | P/B | ||||
|---|---|---|---|---|---|---|---|
| BE |
M
|
MDxHealth SA
NASDAQ:MDXH
|
157.9m USD | 1.5 | -4.7 | -13.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -164 720.7 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.5 | -110.8 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 21.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 7.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.5 | 29 | 6.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -5 465.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.3 | 2.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.2 | 2.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | 18.2 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.6B USD | 10.9 | 129.6 | 51.5 |
P/S Multiple
P/E Multiple
P/B Multiple
